Newsletter Insights — advertising rates and audience data for 32K+ newsletters
Browse all →
Advertisers are viewing this page. Claim it
Track Biotech Snap's growth
Get notified when subscribers, engagement, or pricing changes
Platform Portability
Uses custom domain (biotechsnap.com) — can migrate to any platform without losing subscribers
Are you a newsletter creator? Get verified insights →
A daily 5-min biotech briefing
Data updated Yesterday
Track CPM rates as they change
Start tracking — free$26–$59
Based on Health category benchmarks
We began tracking Biotech Snap 16 days ago. A growth trend will appear once we have more data points.
| Public |
| BMS and Hengrui Pharma sign a $15.2 billion alliance & Boehringer secures a preclinical antibody from Immunitas for $478 millionMay 13, 2026 | Public |
| Cellular Intelligence gives Novo's Parkinson ́s program a second life & Inhibrx reports encouraging phase 2 dataMay 12, 2026 | Public |
| Odyssey Therapeutics goes public with $279 million IPO & Roche acquires PathAI for up to $1.05 billionMay 11, 2026 | Public |
| Angelini Pharma is buying Catalyst for $4.1 billion & InflaRx secures $150 million for its pivotMay 8, 2026 | Public |
| Bayer purchases eye therapy specialist Perfuse for $2.45B & GSK signs $1B deal in China to target stubborn belly fatMay 7, 2026 | Public |
| Cytospire raises $83M to advance its gamma-delta T-cell engagers & Madrigal deepens its MASH pipeline with $1B Arrowhead dealMay 6, 2026 | Public |
| UCB bets $2.2B on Candid's T-cell engagers & Windward raises $165M to challenge asthma leadersMay 5, 2026 | Public |
| Three biotech raise $856M in IPOs & FDA clears Arvinas’ first-in-class PROTAC breast cancer drugMay 4, 2026 | Public |
| Chiesi expands rare disease footprint with $1.9B KalVista acquisition & Teva bets $700M on late-stage Tourette drugApr 30, 2026 | Public |
vs 167 newsletters in Health
1K places you in the top 50% of newsletters in this category.
Engagement Rate
0.00%
median: 0.00%
Posts per Week
7.7
median: 1.0
Publishing Consistency
82/100
median: 65/100
Subscribers
1K
median: 1K
Here's what we know about this newsletter's activity:
Publishing Pace
Daily
Very Consistent
Category Rank
#321 of 830
in Health
Engagement Trend
Building
too early to measure
Psychology Best Practice Newsletter
1K subs
Desfibrilando Vidas
1K subs
The Laundry List
1K subs
Get email alerts when subscribers drop or spike, when new sponsors appear, when pricing changes, or when publishing cadence shifts. Track unlimited newsletters across your watchlist with the Starter plan.
$29/mo·cancel anytime
See what's includedGet the full whitespace list with each brand's category fit, audience overlap, and recommended pitch order. Plus a comparison of Biotech Snap vs the top 15 peer newsletters on sponsor mix, growth, and CPM.
Including WHOOP, Novo Nordisk, Brooklinen + 4 more.
$300·2-3 working days·refunded if we can't deliver
Publishing Frequency
Daily
Last published May 18, 2026
7.7 posts/week avg
Health Pricing
$6/mo median
Your newsletter: Free
Monetization Readiness
Health newsletters typically start charging at ~2K subscribers
50% of typical monetisation threshold
100% of similar-size Health newsletters have paid tiers
Unlock revenue estimates, CPM benchmarks, and detected sponsors
Start tracking — freeFree in a Paid Category
Free newsletter in Health where the median paid tier is $6/mo — accessible to a wider audience.